Bottisham, Cambridgeshire-based Cambridge Cognition, which develops digital health products for brain health assessment, has appointed Alex Livingstone-Learmonth as chief commercial officer and Annabelle Miles as head of marketing.

The two executives are tasked with supporting the company’s growth strategy, implementing processes to build the order book, and increasing awareness and brand exposure for its offering and technology. 

Livingstone-Learmonth has worked in the clinical trial technology, services and solutions industry for more than 20 years. He was previously vice-president at Calyx and Signant Health (initially CRF Health).

Miles started her career at M&C Saatchi and McCann Worldwide, accumulating more than 10 years’ experience in advertising and marketing and worked at Fundamentalvr, a health virtual reality start-up. Her most recent position at Huma involved spearheading a lead-generation strategy for marketing healthcare solutions and clinical trials. 

Cambridge Cognition’s chief executive Matthew Stork said: “At this critical phase in our growth trajectory, I am delighted to welcome Alex and Annabelle to the business. Both have significant sector experience, and I am confident they will provide valuable expertise in their roles as we continue to drive growth.”

Livingstone-Learmonth commented: “I’m delighted to join Cambridge Cognition and leverage my industry experience to help the team deliver its next phase of growth. This is an exciting business, with amazing potential, especially when looking at our core three products: cognitive assessments, eCOA and our automated quality assurance tool.”

Miles added: “I am passionate about healthtech and Cambridge Cognition’s proposition and commitment to providing digital solutions to assess brain health. I look forward to supporting the team as we do our upmost to drive sales to deliver against the company’s significant growth potential.”